PHS
OPTN

PFM Health Sciences’s OptiNose OPTN Stock Holding History

PFM Health Sciences’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-22,286
Closed -$6.69M – 121
2018
Q1 		$6.69M Buy
22,286
+758
+4% +$210K 0.14% 85
2017
Q4 		$6.1M Buy
+21,528
New +$6.06M 0.14% 77

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

PFM Health Sciences's OPTN Position: Q2 2018 in Review

PFM Health Sciences sold out of OptiNose (OPTN) in Q2 2018, closing a stake of 22,286 shares — an estimated $6.69M sold.

PFM Health Sciences first reported a position in OPTN in Q4 2017 and held it in 2 quarters. The position peaked at $6.69M in Q1 2018. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2018.

  • PFM Health Sciences reported no remaining OptiNose position as of Q2 2018 after selling out during the quarter.
  • PFM Health Sciences sold 22,286 OptiNose shares in Q2 2018, an estimated $6.69M.
  • PFM Health Sciences first reported a position in OptiNose in Q4 2017 and held it in 2 quarters.
  • PFM Health Sciences's OptiNose position peaked at $6.69M in Q1 2018.
  • 72 funds tracked by Wall St. Rank held OptiNose as of Q2 2018.

Based on PFM Health Sciences's 13F filing for Q2 2018, filed 14 Aug 2018.